Timing of surgery for ruptured supratentorial arteriovenous malformations by Hafez, Ahmad et al.
ORIGINAL ARTICLE - VASCULAR
Timing of surgery for ruptured supratentorial arteriovenous
malformations
Ahmad Hafez1 & Elias Oulasvirta1 & Päivi Koroknay-Pál1 & Mika Niemelä1 &
Juha Hernesniemi1 & Aki Laakso1
Received: 16 June 2017 /Accepted: 28 August 2017 /Published online: 11 September 2017
# Springer-Verlag GmbH Austria 2017
Abstract
Background There are conflicting opinions regarding the op-
timal waiting time to perform surgery after rupture of
supratentorial arteriovenous malformations (AVMs) to
achieve the best possible outcome.
Objective To analyze factors influencing outcomes for rup-
tured supratentorial AVMs after surgery, paying particular at-
tention to the timing of the surgery.
Methods We retrospectively investigated 59 patients admitted
to our center between 2000 and 2014 for surgical treatment of
ruptured supratentorial AVMs. We evaluated the effect of
timing of surgery and other variables on the outcome at 2–
4 months (early outcome), at 12 months (intermediate out-
come) after surgery, and at final follow-up at the end of
2016 (late outcome).
Results Age over 40 years (OR 18.4; 95% CI 1.9–172.1;
p = 0.011), high Hunt and Hess grade (4 or 5) before surgery
(OR 13.5; 95% CI 2.1–89.2; p = 0.007), hydrocephalus on
admission (OR 12.9; 95% CI 1.8–94.4; p = 0.011), and over
400 cm3 bleeding during surgery (OR 11.5; 95% CI 1.5–86.6;
p = 0.017) were associated with an unfavorable early out-
come. Age over 40 years (OR 62.8; 95% CI 2.6–1524.9;
p = 0.011), associated aneurysms (OR 34.7; 95% CI 1.4–
829.9; p = 0.029), high Hunt and Hess grade before surgery
(OR 29.2; 95% CI 2.6–332.6; p = 0.007), and over 400 cm3
bleeding during surgery (OR 35.3; 95% CI 1.7–748.7;
p = 0.022) were associated with an unfavorable intermediate
outcome. Associated aneurysms (OR 8.2; 95% CI 1.2–55.7;
p = 0.031), high Hunt and Hess grade before surgery (OR 5.7;
95% CI 1.3–24.3; p = 0.019), and over 400 cm3 bleeding
during surgery (OR 5.8; 95% CI 1.2–27.3; p = 0.027) were
associated with an unfavorable outcome at last follow-up.
Elapsed time between rupture and surgery did not affect early
or final outcome.
Conclusions Early surgery in patients with ruptured
supratentorial arteriovenous malformation is feasible strategy,
with late results comparable to those achieved with delayed
surgery. Many other factors than timing of surgery play sig-
nificant roles in long-term outcomes for surgically treated rup-
tured supratentorial AVMs.
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Introduction
The definitive treatment of cerebral arteriovenous
malformations (AVMs) remains complete microsurgical re-
moval by an experienced surgeon [4, 9, 12, 21, 23, 24, 39,
47, 51, 52]. However, it is considered to be one of the most
difficult neurosurgical tasks [1, 52]. The policies of delayed
surgery, as well as staged or combined treatments, have been
described in previous studies [3, 14, 50]. However, partial
obliteration of brain AVM includes a high risk of hemorrhage
[22, 23]. Although the number of incidentally discovered
AVMs is increasing, acute intracranial hemorrhage remains
the most common presenting symptom [2, 13, 30, 31, 49],
and AVM is a major cause of hemorrhage in the young [11,
28, 29, 42, 43].
It has been found that the average annual rate of hemor-
rhage is 2–3% in most studies, but it is highly dependent on
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various risk factors [18, 25, 31, 32, 37, 40, 46, 48, 51], and
ruptured AVM harbors a higher rate of re-bleeding [18, 19, 23,
25, 46]. In previous studies, the rate of re-rupture tripled for
the first few years, and remained double for decades [16, 18,
28, 36, 46, 48]. During the first year, the risk of re-bleeding
may be as high as 16% [17]. There is a higher probability that
the next bleeding will occur in the short term [10, 16, 28], and
it has a case fatality rate [31, 44, 48].
The timing of surgical treatment for ruptured AVMs has
been a controversial topic, and it has been suggested that it
may be beneficial to delay this treatment until the edema
has subsided and the clinical condition of the patient has
improved [6, 20]. The fact that AVMs are less prone than,
for example, intracranial aneurysms to re-bleed very early
has been used to support this suggestion. However, from
the surgical perspective, fresh AVM bleeding may even
facilitate surgical resection; a hematoma cavity offers a
wide corridor and creates a good cleavage plane, and
bleeding itself releases a high flow inside the nidus [24,
33, 47]. Several neurosurgeons have rationalized early sur-
gery on the basis that ruptured AVMs may cause a life-
threatening mass effect, due to expansive hematoma [5,
7, 27, 38, 45, 51]. In addition to removal of the clot, sur-
gical treatment of the AVM can remove the lesion and
immediately eliminate the risk of a new hemorrhage.
Immediate eradication of the AVM may also facilitate the
rehabilitation of the patient, whereas in the case of delayed
treatment, the patient must recover twice: first from the
hemorrhage, and later from the AVM treatment. It has long
been our policy to treat ruptured AVMs without unneces-
sary delays after the necessary preoperative investigations
have been carried out; in unconscious patients with life-
threatening hematomas within a few hours, and usually
within few days in others.
In the present study, we reviewed our recent experience of
surgical treatment of ruptured supratentorial AVMs and ana-
lyzed the clinical outcomes, with regard to different time in-
tervals between rupture and surgery. The timing of surgery
was analyzed together with other factors that potentially affect
outcomes.
Methods
The data were retrospectively retrieved from the Helsinki
AVM Database, Finland, which includes all patients with
brain AVMs who have been admitted to the Department of
Neurosurgery at Helsinki University Hospital, Helsinki,
Finland, since 1942 (805 patients had been admitted by
the end of 2014), with a population responsibility and cur-
rent catchment area of 1.8 people. The ethical committee of
the Helsinki University Hospital approved the study.
Patient selection and clinical data
The main selection process began by the selection of patients
with ruptured supratentorial AVMs who had been admitted
from 2000 to 2014, with a maximum delay of 1 year between
the rupture and AVM surgery. The patients were followed up
until death or during 2016. Those treated before 2000 were
excluded because the original imaging was not necessarily
available for review. Ending inclusion at the end of 2014
allowed a minimum of 1 full year of follow-up, with a survey
performed during 2016. Infratentorial AVM patients were ex-
cluded, because infratentorial hemorrhage often necessitates
immediate surgery, and timing is less controversial. We ana-
lyzed only patients who had been operated on by one of the
senior authors (J.H.), who performed the vast majority of
AVM operations during the study period in our center, to
minimize variability caused by surgeon experience.
In addition, the following exclusion criteria were applied to
patient selection, to minimize confounding factors potentially
affecting clinical outcomes or data analysis:
1- Foreign patients leaving Finland immediately after treat-
ment, that is, no structured late follow-up data were reli-
ably available
2- Uncertain timing of AVM rupture
3- Surgery for an AVM had not been planned, that is, the
AVM diagnosis was initially missed and made only peri-
or postoperatively in a patient operated on for what was
initially thought to be a spontaneous intracerebral
hemorrhage
4- The AVM ruptured after/due to another modality of treat-
ment (embolization or radiotherapy) had been received
for an originally unruptured AVM.
5- Cases in which the AVM was not the source of the hem-
orrhage (AVM-unrelated bleeding in an AVM patient)
6- Patients who had severe heart failure or cancer
The timing of surgery in this retrospective cohort was de-
pendent on many factors, including the clinical condition, the
referral policy of the referring hospitals, surgeon discretion
and availability, and patient-family agreement. The surgical
procedure included cautious dissection and identification of
all of the vessels in the vicinity of the AVM, carefully saving
the draining vein until the end of the removal, and thorough
inspection of the resection bed, as well as securing the final
steps of hemostasis, using “dirty coagulation” of tiny deep
feeders [24].
Diagnosis of AVM and hemorrhage was usually based on
computed tomography (CT) and CT angiography (CTA), or
magnetic resonance imaging (MRI). Four-vessel digital sub-
traction angiography (DSA) was always performed, unless the
clinical condition required immediate emergency evacuation
of the hematoma, in which cases AVM diagnosis was based
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on CTA. Total excision of the AVM was verified by postop-
erative DSA in 95% of the cases.
Pre and perioperative clinical and demographic data were
collected from hospital records, and anatomical details were
evaluated from the original imaging and the radiologist’s re-
ports. Since there are no AVM rupture-specific grading scales,
we used Hunt and Hess score to rate the clinical condition of
the patients upon arrival and immediately before surgery. It is
based on patient’s clinical neurological condition, taking into
account the presence of focal deficits (usually caused by intra-
parenchymatous hematoma), and the level of consciousness
dictated mainly by the severity of the bleeding. The outcome
was based on hospital records as follows: using the Glasgow
Outcome Scale (GOS) at 2–4 months (early outcome) and at
12 months (intermediate outcome) after surgery, and the mod-
ified Rankin Scale (mRS), based on questionnaires completed
by patients or relatives in 2016 (final outcome) for the patients
who were alive. The early and 12-month outcomes were esti-
mated from hospital records using, the Glasgow Outcome
Score (GOS), which can be reliably evaluated from the avail-
able data even retrospectively. For the late follow-up, the mRS
are based on actual questionnaires designed to evaluate time-
specific mRS scores.
The date and cause of death of deceased patients was ob-
tained from Statistics Finland (a Finnish public authority that
maintains nationwide registries).
Statistical analysis
We performed univariate analyses to evaluate the associations
between each variable and outcome at different time points (as
described above). Pearson Chi-square tests were performed to
compare categorical variables, and the Mann–Whitney U test
was used to compare continuous variables. In order to evalu-
ate independent factors affecting outcome, a binary logistic
regression model was constructed, using the Wald method
(first entering variables into the model and then using stepwise
backward elimination). Stepwise logistic regression was used
in multivariate analysis to identify independent predictors of
dichotomized outcomes (favorable vs. poor, defined as GOS
1–2 vs. 3–5, or m RS 0–2 vs. 3–6). The association between
the timing of surgery and duration of intensive care unit (ICU)
treatment was studied using Spearman’s non-parametric cor-
relation. The statistical tests were two-sided, and p < 0.05 was
considered statistically significant. The statistical analysis was
performed using Statistical Package for the Social Sciences
software, version 22 (SPSS Inc., Chicago, IL, USA).
Results
Of the 805 patients attending our department with brain AVM
between 1942 and 2014, 59 met the inclusion criteria. Full
patient-related information on admission is presented in
Tables 1 and 2, and perioperative information is shown in
Table 3. The mean age of the patients was 40.5 years (SD
18.8 years), 30 were male (51%) and 29 were female (49%).
The majority attended with neurological deficits (40% severe,
25% mild). Twelve (20%) developed hydrocephalus before
surgery, and nine (15%) presented with epilepsy.
The medianmaximum diameter of hemorrhage was 44mm
(SD, 24.7, range, 0–80). Intraventricular bleeding was ob-
served in 26 (44%) patients. Re-bleeding before surgery oc-
curred in three patients (see below for further details). The
AVM size was over 30 mm in 20 (34%) cases. The AVM
was located in a deep position in 22 (37%) patients, and the
nidus was diffuse in 12 (20%) cases. The AVMwas located in
an eloquent area in 29 (49%) patients. Deep venous drainage
was present in 13 (22%) cases, 14 (24%) AVMs were fed by
deep perforators, and flow-related aneurysms were observed
in seven (12%) cases.
The median time from AVM rupture to surgery was 2 days
(range, 0–360 days). A total of 37 (62%) patients underwent
surgery within 4 days of rupture. Surgery was performed on
the day of bleeding (day 0) in 18 (30%) patients. In 13 (22%)
patients, the AVMwas embolized before surgery. The average
amount of bleeding during surgery was 448 cm3 (SD,
1045 cm3, range, 50–7000 cm3). Only nine (15%) patients
required a blood transfusion. We achieved total exclusion of
the AVM at first surgery in 57 patients (96%). One patient
underwent a further operation because of re-bleeding from
the resection bed of the AVM following surgery. The patient
showed a worse post-operative result and had died before
early follow up (2–4 months). Another patient had a second
operation because of residual filling of the AVM. This patient,
who had presented with a focal neurological deficit at admis-
sion, improved slowly to have moderate disability at final
follow-up.
Three patients (5%) died in hospital due to AVM-related
reasons during first hospitalization. Another six (10%) pa-
tients died before final follow-up (2016), two as a result of
AVM-related complications. In univariate analysis (Table 4),
poor early outcome (GOS at 2–4 months) was significantly
Table 1 Descriptive statistics for continuous variables for the 59
patients who met the inclusion criteria
Median/mean SD SEM Range
Age, years 40 /40.5 18.8 2.4 0–71
Hunt and Hess at admission 4 /4.1 1.2 0.2 1–6
Hematoma largest diameter, mm 44 /38.9 24.7 3.2 0–80
Rupture to surgery, days 2 /30.0 72.3 9.4 0–360
ICU days 5 /7.3 5.5 0.7 0–23
Hospital days 12 /13.1 7.1 0.9 2–30
SD standard deviation, SEM standard error of the mean
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Table 2 Descriptive statistics for
categorized variables for the 59
patients who met inclusion
criteria
Factor Categories Frequency Percent
Gender Male 30 51
Female 29 49
Embolization before surgery Yes 13 22
No 46 78
Spetzler–Martin grade <3 31 53
=3 16 27
>3 12 20
Supplemented Spetzler–Martin grade <6 35 59
=6 10 17
>6 14 24
AVM size, cm < 3 cm 39 66
> 3 cm 20 34
Location Deep 22 37
Superficial 37 63
Hydrocephalus at admission Yes 12 20
No 47 80
Epilepsy at admission Yes 9 15
No 50 85
Nidus Diffuse 12 20
Compact 47 80
Eloquence Yes 29 49
No 30 51
Venous drainage Deep 13 22
Cortical 32 54
Deep and cortical 14 24
Perforator Yes 14 24
No 45 76
AVM flow-related aneurysm Yes 7 12
No 52 88
Intraventricular blood Yes 26 44
No 33 56
Amount of bleeding during surgery < 400 cm3 47 80
> 400 cm3 12 20
Bleed transfusion Yes 9 15
No 50 85
Immediate post operation result Better 12 20
Worse 16 27
Same 31 53
2–4 months GOS Favorite 43 73
No 16 27
12 month GOS Favorite 44 75
No 15 25
Last mRS follow-up (end 2016) Favorite 44 75
No 15 (9 dead) 25
Days at hospital <14 24 41
>14 35 59
ICU days <7 34 58
>7 25 42
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associated with age > 40 (p = 0.004; OR 6.6), deep perforators
(p = 0.027; OR 4.0), associated aneurysms (p = 0.004; OR
9.3), focal neurological deficits (p = 0.050; OR 3.1), hydro-
cephalus before surgery (p = 0.000; OR 2.1), hypertension at
admission (p = 0.010; OR 1.2), bleeding over 400 cm3 during
surgery (p = 0.047; OR 3.7), and high preoperative Hunt and
Hess grade (4 or 5) (p = 0.000; OR 9.6).
Poor intermediate outcome (GOS at 12 months) analysis
revealed a significant univariate association with age > 40
(p = 0.001; OR 10.3), associated aneurysms (p = 0.000; OR
28.6), high Hunt and Hess grade before surgery (p = 0.001;
OR 7.8), hydrocephalus (p = 0.029; OR 4.2), and bleeding
more than 400 cm3 during surgery (p = 0.003; OR 6.8).
Poor final outcome (mRS >2 at final follow-up in 2016) was
associated with age > 40 (p = 0.044; OR 3.6), associated
aneurysms (p = 0.002; OR 10.5), high Hunt and Hess grade
before surgery (p = 0.007; OR 5.1), bleeding > 400 cm3 during
surgery (p = 0.003; OR 6.8), and nidus diffuseness (p = 0.029;
OR 4.2).
In a multivariate logistic regression model for poor early
outcome, stepwise (Walt) backward elimination identified
four main factors with significant effect (Table 5).
Significant factors were age > 40 (p = 0.011; OR 18.4), high
Hunt and Hess grade before surgery (p = 0.007; OR 13.5),
hydrocephalus before surgery (p = 0.011; OR 12.9), and more
than 400 cm3 of bleeding during surgery (p = 0.017; OR 11.5).
For poor intermediate outcome, the significant factors were
age > 40 (p = 0.011; OR 62.8) associated aneurysms
(p = 0.029, OR 34.7), high Hunt and Hess grade before sur-
gery (p = 0.007; OR 29.2), and more than 400 cm3 of bleeding
during surgery (p = 0.022; OR 35.3) (Table 6).
For poor final outcome, significant factors were associated
aneurysms (p = 0.031; OR 8.2), high Hunt and Hess grade
before surgery (p = 0.019; OR 5.7), and more than 400 cm3 of
bleeding during surgery (p = 0.027; OR 5.8) (Table 7).
Time interval from bleeding to surgery was not significant-
ly associated with outcome at any time points, according to
univariate or multiple regression analyses. Moreover, a non-
parametric Spearman correlation was not significant between
time interval to surgery and the number of days spent in the
ICU (p = 0.82, Spearman’s rho interval bleeding to surgery
correlation coefficient 1.000). We also analyzed the influence
of timing to surgery in only those 40 patients, where preoper-





Acute hydrocephalus before surgery 12
Another bleeding before surgery 3
Severe focal neurological deficits 24
Mental deterioration 10
Pre-surgery other problem (respiratory (2), high blood pressure (10), kidney (1), psychological (3),
coagulopathies (2), urinary infection (3), diabetics (3), atherosclerosis (5), gastrointestinal (1)
*
Surgery done at the same day of rupture (0 day) 18
Surgery done within 4 days of rupture 37
Permanent ligation major vessel during surgery 1
Temporary ligation vessel during surgery 10
Thrombosis efferent vessel 1
Post-operative subdural hematoma 2
Post-operative intracerebral hematoma 3
More than one surgery (hematoma, shunt...) 11
More than one surgery for the AVM 2
Total excluded by first surgery 57
Death related to AVM after ruptured during first hospitalization 3
All deaths at last follow-up (2016) 9
Postoperative venous thrombosis (leg) 3
Post-operative arterial spasm 4
Use of epileptic drug at any time (8 just loading dose) 40
New using of epileptic drug after surgery 7
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patients) which should exclude those critically ill high-grade
patients who will need immediate emergency operation be-
cause of large expansive hematomas. Even in this subcohort,
the time to surgery in univariate analyses (analyzed in the
same way as for whole cohort) did not show any effect.
The outcome for the three patients who had early re-bleeding
before surgery was as follows: the first patient was 60 years old,
with a deep 27 mm AVM associated with a small pericallosal
aneurysm, and presented with a severe headache and focal neu-
rological deficit. The second bleeding occurred after 3 months.
The final outcome was not favorable, with severe disability. The
second patient, whowas aged 71 years and had a small temporal
cortical AVM, presented with focal deficits and was operated on
after 4 days with a new bleed. The final outcome was favorable,
with moderate disability. The third patient, aged 21 years and
with a basal ganglion AVM, bled again after 6 months with
intraventricular bleeding, and was dead after 9 months.
Embolization before surgery did not show a significant
influence on early, moderate, or late outcomes (p = 0.716,
0.829, and 0.829, respectively) Table 4. However, related var-
iables of the preoperative embolized and non-embolized cases
were analyzed; the AVM characteristics, surgical aspects, and
outcomes are presented in Table 8.
Table 4 Univariate analysis of variables associated with worse 2–4 months GOS (early outcome), 12-months GOS (moderate outcome), and last mRS
follow-up 2016 (late outcome)









Age > 40 0.004/6.6 0.001/ 10.3 0.044/3.6
Gender 0.218 0.713 0.339
Hypertension 0.010/1.2 0.253 0.253
Epilepsy at admission 0.652 0.815 0.823
Focal neurological deficit at admission 0.050/3.1 0.113 0.328
Hydrocephalus before surgery 0.000/2.1 0.029/4.2 0.489
Blood in ventricle 0.234 0.341 0.341
Re-bleeding before surgery (3 cases) 0.760 0.094 0.094
Hematoma larger diameter<40 mm> 0.651 0.159 0.833
Hunt and Hess on admission<4> 0.306 0.130 0.392
Preoperative Hunt and Hess<4> 0.000/9.6 0.001/7.8 0.007/5.1
Embolization before surgery 0.716 0.829 0.829
AVM size in mm 0.732 0.993 0.292
Venous drainage 0.258 0.818 0.411
Deep perforator 0.027/4.0 0.089 0.089
Associated aneurysm 0.004/9.3 0.000/28.6 0.002/10.5
AVM location (Superficial/ deep) 0.068 0.142 0.393
Nidus (compact/ diffuse) 0.211 0.153 0.029/4.2
Eloquence location 0.514 0.339 0.827
Bleeding during surgery > 400 0.047/3.7 0.003/6.8 0.003/6.8
Interval time to surgery, days 0.392 0.348 0.823
Surgery within 4 days of rupture 0.392 0.333 0.719
Numbers in bold specify a significance p-value < 0.05
Table 5 Factors significantly associated with worse early outcome in
multiple logistic regression model (Walt stepwise backward model)
Factor P value OR 95% CI
Age > 40 0.011 18.4 1.9–172.1
Hunt and Hess before surgery >4 0.007 13.5 2.1–89.2
Hydrocephalus at admission 0.011 12.9 1.8–94.4
Bleeding during surgery > 400 cm3 0.017 11.5 1.5–86.6
OR odds ratio, CI confidence interval
Table 6 Factors significantly associated with worse intermediate
(12 months) outcome in multiple logistic regression model (Walt
stepwise backward model)
Factor P value OR 95% CI
Age > 40 0.011 62.8 2.6–1524.9
Associated aneurysm 0.029 34.7 1.4–829.9
Hunt and Hess before surgery 0.007 29.2 2.6–332.6
Amount of bleeding during surgery 0.022 35.3 1.7–748.7
OR odds ratio, CI confidence interval
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Discussion
Surgical intervention is considered to be a definitive strategy
for the treatment of ruptured cerebral AVM, providing imme-
diate cure and prevention of rebleeding [8]. However, there is
a lack of consensus regarding the timing of the operation, and
it remains a subject of considerable variation in clinical prac-
tice. There are two basic approaches to ruptured AVM treat-
ment. The first of these is a primary surgical approach at an
early stage, and the second is a primary conservative treat-
ment, followed by delayed surgical, endovascular, or
radiosurgical intervention, or a combination thereof.
However, emergency craniotomy may be life-saving, and is
the only appropriate solution in many cases [26].
We conducted a retrospective analysis of surgically treated
ruptured supratentorial AVMs to evaluate the influence of
timing of surgery on early and late outcome. Deep perforators,
high Hunt and Hess grade before surgery, age over 40, hydro-
cephalus, amount of bleeding during surgery, and AVM-
related aneurysms were associated with an increased likeli-
hood of poor surgical outcomes. The homogenous selection
of our study population, as well as utilization of a multivariate
model, aimed to enable the analysis of the time interval be-
tween bleeding and surgery as a potential predicting factor
with regard to outcome, among other potential prognostica-
tors. In this cohort, the time interval between AVM bleeding
and surgery did not influence early or late outcome, and the
role of those factors that did affect outcome are primarily
understandable. For example, it is not surprising that
increasing age, increasing bleeding severity (as assessed using
Hunt and Hess grade), or the presence of hydrocephalus were
associated with a worse outcome. It is known that the presence
of deep perforators makes AVM surgery more challenging
[15], and the greater amount of blood loss during surgery is
likely indicative of larger and more complex lesions.
In the early era of microsurgical AVM treatment, acute
intervention for ruptured AVMs was considered relatively
contraindicated, as the risk of each recurrent hemorrhage from
AVM was comparable with the same risk from a re-ruptured
aneurysm [34]. This opinion originated from a concern of
potentially damaging the brain tissue on a confusing hemor-
rhagic background. This was the main reason that non-
surgical therapy wasmore frequently chosen, and for the delay
of surgical intervention until the hematoma had subsided. As
experience in microsurgical AVM treatment increased, the
degree of peri-nidal brain injury decreased, and the willing-
ness to target these lesions earlier after hemorrhage also in-
creased. This initiated the discussion concerning the correct
timing of microsurgical dissection of the cerebral AVM. Few
studies have focused on the optimal timing of this operation.
However, early surgery for ruptured cerebral AVM, evenwith-
in a timeframe of a few hours or days, may currently be con-
sidered in experienced centers. However, others recommend
emergency hematoma evacuation with delayed AVM excision
as a safe strategy in certain situations [35]. Although a 4-week
interval has been recommended in some studies, the exact
waiting period remains controversial [6, 35].
Our study showed that there appears to be no significant
advantage in delaying surgical treatment for ruptured
supratentorial AVMs, as the long-term outcomes for
immediately/early treated patients were comparable to those
treated after longer delays. This is despite the fact that those
patients with life-threatening hematomas, and therefore in the
poorest initial clinical condition, were naturally treated with
minimal delays. In contrast, early surgical intervention may
(1) facilitate early rehabilitation, (2) decrease the likelihood of
reappearance of focal neurological deficits upon surgery, as
may well happen if performed after the initial recovery period
Table 7 Factors significantly associated with worse late outcome in
multiple logistic regression model (Walt stepwise backward model)
Factor P value OR 95% CI
Associated aneurysm 0.031 8.2 1.2–55.7
Hunt and Hess before surgery 0.019 5.7 1.3–24.3
Amount of bleeding during surgery 0.027 5.8 1.2–27.3
OR odds ratio, CI confidence interval
Table 8 Pre-operation embolized
and not embolized AVM
characteristics, surgical aspects,
and outcome
Embolized AVM (13 cases) Non embolized AVM (46 cases)
AVM >30 mm 8 4
Deep vein 11 15
Deep perforator 7 7
Nidus (diffuseness) 6 6
Bleeding > 400 cm3 during surgery 6 6
Within 4 days (ruptured to surgery) 6 31
Early favorite outcome 10* 33*
Moderate favorite outcome 10* 34*
Late favorite outcome 10* 34*
*Embolized AVMs have no different percentage outcome
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(often temporary, but still requiring a new rehabilitation peri-
od), (3) prevent the risk of re-bleeding during the recovery
period while waiting for definitive treatment, and (4) decrease
medical expenses. For decades, it has been the policy of one of
the senior authors (J.H.) to treat ruptured AVMs without delay
whenever possible, and, with experience, the surgery is defi-
nitely feasible, even in these acute situations. In most urgent
situations, surgery must be performed using only the informa-
tion given by CT and CTA, but usually the condition of the
patient allows the performance of DSA. In selected cases,
preoperative OnyxR embolization may facilitate surgical treat-
ment. Preoperative MRI may also be beneficial for surgical
planning, if the patient’s condition allows. During surgery, the
correct neuroanesthesiological principles [41] are mandatory
to control blood pressure and to provide “slack brain” to op-
timize the microsurgical circumstances. Postoperative DSA
control is performed on the same, or, at the latest, the next,
day to verify complete eradication of the lesion. After AVM
resection and hematoma evacuation, controlled hypotension is
administered at the ICU, the duration and depth of which
depends on the complexity and size of the lesion. We usually
aim for < 100 mmHg at least for the first 24 h after surgery,
unless compromised cerebral perfusion pressure necessitates
higher systemic blood pressure.
Our results still keep the door open for either strategy, de-
pending on the individual patient and the experience of the
team. However, with sufficient microsurgical experience, ear-
ly surgery for ruptured AVMs is certainly feasible and can be
justified for the above-mentioned reasons. Obviously, life-
threatening hematomas necessitate immediate intervention,
and our recommendation is to eradicate the AVM in the same
operation, if possible. Avoiding peri- and postoperative com-
plications and optimizing ICU treatment are also likely to
influence outcomes.
Limitations of the studyAlthough the strict inclusion criteria
decreased the influence of potential confounding factors, it
limited our patient population and may have introduced some
selection bias to the cohort. However, potential selection bias
was decreased by the fact that ours is the only neurosurgical
referral center for our catchment area (1.8 million people). We
chose cases of a single experienced neurosurgeon, in order to
minimize surgeon experience as a confounding factor.
However, this may limit the generalizability of the findings.
Prospective studies involving a larger number of neurosur-
geons and centers are required to validate the findings of this
study.
Conclusions
The present study showed that the time interval from AVM
rupture to surgery did not affect long-term outcomes. The
optimal timing of surgery for ruptured supratentorial AVMs
remains unestablished, but since delayed surgery does not
appear to produce any advantage, we recommend early sur-
gery to facilitate early rehabilitation and to prevent early re-
bleeding.
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Comments
We have here a study from a renowned senior surgeon and an experienced
group regarding early surgery approach to ruptured intracranial AVMs.
The analysis is done on 59 patients culled from a total experience of 805
patients. It is a fractional sample of the overall group, but this is because
careful steps were taken to ensure a complete dataset in analyzed patients.
The data is instructive even though it is a small subset of the Helsinki
AVM experience.
The raw data is impressive, no doubt because of the quality of this
highly experienced team and center, and their ability to transfer patients
quickly from throughout Finland. Mean time to surgery was 2 days.
Complete excision at first surgery was achieved in 96% of patients.
Mortality was 15%. Deep perforators, high Hunt-Hess grade before sur-
gery (note that they have used Hunt and Hess grading for AVMs in the
absence of a truly dedicated AVM hemorrhage acuity grading system),
age over 40, hydrocephalus, amount of bleeding during surgery, and
AVM-related aneurysms were associated with an increased likelihood
of poor surgical outcomes. Importantly, neither time to surgery nor em-
bolization before surgery were associated with significant differences in
outcome.
This study impacts the practice of AVM surgery in several important
ways. Unlike aneurysmal subarachnoid hemorrhage, in this series a
policy of early AVM surgery is neither better nor worse than a policy of
delayed surgery, except of course where life-threatening ICH and mass
effect are present, and early surgery is thus mandated. The study also
codifies that risk factors which AVM surgeons know intuitively to be
negative predictors of outcome, like excessive bleeding, deep feeders,
poor patient condition and the others outlined above, are validated by this
analysis.
The only reservation about this paper is that of course this is a tiny
subset of the extensive Helsinki experience. However, we can understand
why they chose to do it this way, to obtain the best possible dataset, and
we accept and recommend the article as a quality observation of many
things, but especially that early AVM surgery is reasonable and can be
associated with similar outcomes to delayed surgery if the team and
facility is available and the surgeon elects this practice.
Christopher M. Loftus,
Philadelphia, PA, USA
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